Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEMOPHENO: Hemodynamic Phenotype-Guided Antihypertensive Therapy
NCT07240909Phase 4Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of amlodipine, metoprolol, indapamide in hypertension (HTN), sponsored by Third Xiangya Hospital, Central South University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
amlodipinemetoprololindapamide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07240909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240909.